Wedmont Private Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Hold |
20,943
| – | – | 0.01% | 731 |
|
|
2025
Q1 | $121K | Hold |
20,943
| – | – | 0.01% | 681 |
|
|
2024
Q4 | $144K | Buy |
20,943
+2,000
| +11% | +$13.8K | 0.01% | 683 |
|
|
2024
Q3 | $117K | Hold |
18,943
| – | – | 0.01% | 652 |
|
|
2024
Q2 | $158K | Hold |
18,943
| – | – | 0.01% | 620 |
|
|
2024
Q1 | $172K | Buy |
18,943
+2,000
| +12% | +$18.2K | 0.01% | 578 |
|
|
2023
Q4 | $214K | Hold |
16,943
| – | – | 0.02% | 513 |
|
|
2023
Q3 | $115K | Hold |
16,943
| – | – | 0.01% | 487 |
|
|
2023
Q2 | $202K | Buy |
+16,943
| New | +$202K | 0.02% | 474 |
|